Actively Recruiting
A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
Led by Shanghai Hengrui Pharmaceutical Co., Ltd. · Updated on 2024-12-10
100
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this study is to evaluate the effectiveness and safety of SHR-A2102 for participants with advanced gynaecological cancer.
CONDITIONS
Official Title
A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participate voluntarily and sign informed consent
- Have recurrent or metastatic gynecological cancer that failed standard treatments
- Have at least one measurable tumor lesion (RECIST version 1.1)
- Have an ECOG performance status of 0 to 1
- Have adequate organ function
- Female of childbearing potential must agree to use highly effective contraception during treatment and for 7 months after last dose
- Female participants must have a negative HCG test within 72 hours before enrollment and must not be breastfeeding
You will not qualify if you...
- Have untreated brain metastasis, meningeal metastasis, or spinal cord compression
- Have other previous or current cancers unless in complete remission for at least 5 years and not requiring treatment
- Previously received antibody drug conjugates with topoisomerase I inhibitors
- Had major surgery (other than biopsy) within 28 days prior to first dose or minor traumatic surgery within 7 days prior
- Are HIV positive, have active hepatitis B or C
- Had active pulmonary tuberculosis within 1 year prior to enrollment
- Are allergic to any components of SHR-A2102
- Are judged unfit to participate by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
Z
ZhiFei Lin, M.M
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here